Developer docs
API playgroundTry for free, no card

Search company profiles

Wiener lab Group

Full company profile

uuid000cozr

Namestring
Wiener lab Group
Legal namestring
Wiener Laboratorios SAIC
Company typeenum
Private
Founded yearint
1960
Descriptiontext

Wiener lab Group operates as the largest in vitro diagnostic (IVD) company in Latin America, headquartered in Argentina with more than 60 years of operational history. It develops, manufactures, and distributes diagnostic products and services for clinical analysis laboratories, serving hospital, clinic, and reference-lab customers across more than 50 countries. Its portfolio of 500+ solutions is organized into three product layers: instruments (laboratory automation hardware), reagents (clinical chemistry, immunoassay, hematology, and related diagnostic consumables), and tailor-made software for laboratory information management and workflow.

The company runs four dedicated R&D+i (research, development, and innovation) centers staffed by an interdisciplinary team, and pursues a horizontal IVD strategy addressing multiple analytical disciplines rather than specialization in a single assay category. This structure enables cross-platform reagent development and integrated instrument-software bundles. Distribution is hybrid: direct sales and service in core markets, supplemented by a network of authorized distributors in secondary international geographies. The underlying business model follows the classic razor-and-blade economics of the IVD sector — capital equipment placements generate an installed base that pulls through recurring, higher-margin reagent and consumable revenue, while software deepens account stickiness.

Wiener lab is privately held; no funding rounds, M&A activity, or leadership transitions are disclosed in the available input. Operational evidence — sustained international distribution, a 500+ SKU portfolio, four R&D centers, and an active 2026 events calendar — points to a mature, steady-state business rather than a high-growth or turnaround profile. The principal data gaps are quantitative: no revenue, headcount, growth-rate, or customer-concentration disclosures are available, which limits confidence on financial trajectory.

Short descriptiontext

Wiener lab Group is the largest in vitro diagnostic company in Latin America, providing instruments, reagents, and laboratory software to clinical-analysis labs across more than 50 countries from its Argentine base.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRosario, Argentina
HQ citystring
Rosario
HQ countrystring
Argentina
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in vitro diagnostics, clinical chemistry reagents, laboratory automation equipment, diagnostic instruments, laboratory information software
Industry3 codes
PRIMARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAO
Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAN
Maintenance, Service Contracts & Equipment Repair (Field Service, Parts)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Instrument Sales
TypeOne Time License
Description

Sale of clinical analysis instruments and automation equipment to laboratories. Equipment sales represent a significant revenue stream with typically higher transaction values and longer sales cycles associated with enterprise laboratory clients.

wiener-lab.com.ar
2Reagent Sales
TypeSubscription Recurring
Description

Sale of diagnostic reagents and consumables required for clinical testing. Reagent sales provide recurring revenue as laboratories require ongoing supply for continuous diagnostic operations.

wiener-lab.com.ar
3Software Solutions
TypeOne Time License
Description

Sale and licensing of tailor-made IT software solutions for laboratory information management and diagnostic workflow optimization.

wiener-lab.com.ar
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Wiener lab Group is the largest in vitro diagnostic company in Latin America, selling a comprehensive portfolio of more than 500 diagnostic solutions to clinical analysis laboratories. Its offering comprises three core product lines: clinical analysis Instruments (laboratory automation equipment), Reagents (innovative and affordable diagnostic reagent systems), and tailor-made Software (IT solutions for laboratory information management and workflow optimization). The company also provides permanent technical customer support delivered by an interdisciplinary team of biochemists, engineers and technicians.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Wiener lab Group is the largest in vitro diagnostic company in Latin America, offering a unified platform of diagnostic solutions comprising three core product lines: Instruments (laboratory automation equipment), Reagents (diagnostic systems), and Software (IT solutions). Together, these products provide comprehensive solutions for clinical analysis laboratories of various sizes, spanning over 500 diagnostic solutions across more than 50 countries.

Product and service3 records
1Instruments
CategoryClinical Analysis Instruments
Description

Wide range of laboratory equipment designed to automate clinical analysis laboratories of various sizes, providing comprehensive solutions for laboratory automation and clinical analysis workflows. Targeted at clinical analysis laboratories ranging from small standalone labs to large hospital laboratories.

2Reagents
CategoryDiagnostic Reagents
Description

Innovative, reliable, and affordable diagnostic reagent systems used for in vitro diagnostics, forming a core component of the company's diagnostic solution portfolio and providing recurring consumables for clinical laboratories.

3Software
CategoryLaboratory Information Software
Description

Tailor-made IT solutions designed to complement the diagnostic instruments and reagents, providing integrated information technology support for laboratory information management and diagnostic workflow optimization.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Diversified life science and clinical diagnostics company with a clinical IVD portfolio in immunology, blood typing, and QC materials. Comparable in selling reagents and instruments to clinical analysis labs and in emerging-market distribution.

TypeDirect peer
Description

Specialty IVD company with a focused reagent and instrument menu (LIAISON) in clinical chemistry and immunoassays. Comparable in scale, vertically integrated model, and reliance on recurring reagent revenue from clinical labs.

TypeDirect peer
Description

Specialty IVD company focused on microbiology, immunoassays, and clinical chemistry with strong emerging-market presence. Closely comparable business model (instruments + reagents, recurring consumables) and similar target of mid-sized clinical labs in developing markets.

4Beckman Coulter (Danaher)
TypeBroad incumbent
Description

Global IVD player in clinical chemistry, immunoassay, and hematology with strong mid-tier lab presence. Comparable in customer segment, instrument-reagent model, and competition for hospital and reference lab contracts in the region.

TypeEmerging player
Description

Fast-growing Chinese IVD and medical device manufacturer with an aggressive push into Latin America and emerging markets. Directly comparable in targeting mid-tier labs with cost-competitive instruments and reagents.

TypeBroad incumbent
Description

Major IVD and diagnostics informatics provider (Atellica, ADVIA Centaur). Comparable as a full-stack instruments + reagents + LIS competitor in mid- and large-sized hospital laboratories across Latin America.

TypeBroad incumbent
Description

Global IVD leader in hematology and urinalysis with expanding clinical chemistry offerings. Comparable in instruments + reagents model and in competing for routine testing workloads in hospital and reference labs.

TypeDirect peer
Description

Mid-sized IVD company offering clinical chemistry, hematology, and immunoassay instruments and reagents with strong emerging-market focus. Closely comparable in scale, product mix, and pricing-oriented positioning against global giants.

TypeBroad incumbent
Description

Global IVD leader with the broadest integrated instruments/reagents/software portfolio (cobas, Elecsys, etc.). Comparable as the benchmark integrated IVD player that Wiener lab competes against, especially in Latin American hospital labs.

10Abbott Diagnostics
TypeBroad incumbent
Description

Global IVD incumbent with ARCHITECT and Alinity platforms spanning clinical chemistry and immunoassays. Directly comparable in product mix and target customer (clinical analysis labs) and a key competitor across LatAm.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wiener lab Group

In Vitro Diagnosticswiener-lab.com.ar

Wiener lab Group is the largest in vitro diagnostic company in Latin America, providing instruments, reagents, and laboratory software to clinical-analysis labs across more than 50 countries from its Argentine base.

What Wiener lab Group does

Wiener lab Group operates as the largest in vitro diagnostic (IVD) company in Latin America, headquartered in Argentina with more than 60 years of operational history. It develops, manufactures, and distributes diagnostic products and services for clinical analysis laboratories, serving hospital, clinic, and reference-lab customers across more than 50 countries. Its portfolio of 500+ solutions is organized into three product layers: instruments (laboratory automation hardware), reagents (clinical chemistry, immunoassay, hematology, and related diagnostic consumables), and tailor-made software for laboratory information management and workflow.

The company runs four dedicated R&D+i (research, development, and innovation) centers staffed by an interdisciplinary team, and pursues a horizontal IVD strategy addressing multiple analytical disciplines rather than specialization in a single assay category. This structure enables cross-platform reagent development and integrated instrument-software bundles. Distribution is hybrid: direct sales and service in core markets, supplemented by a network of authorized distributors in secondary international geographies. The underlying business model follows the classic razor-and-blade economics of the IVD sector — capital equipment placements generate an installed base that pulls through recurring, higher-margin reagent and consumable revenue, while software deepens account stickiness.

Wiener lab is privately held; no funding rounds, M&A activity, or leadership transitions are disclosed in the available input. Operational evidence — sustained international distribution, a 500+ SKU portfolio, four R&D centers, and an active 2026 events calendar — points to a mature, steady-state business rather than a high-growth or turnaround profile. The principal data gaps are quantitative: no revenue, headcount, growth-rate, or customer-concentration disclosures are available, which limits confidence on financial trajectory.

Wiener lab Group firmographics

Firmographics
Name
Wiener lab Group
Legal name
Wiener Laboratorios SAIC
Website
https://wiener-lab.com.ar
Company type
Private
Founded year
1960
Operating status
Operating
Headcount range
1–10 employees
Short description
Wiener lab Group is the largest in vitro diagnostic company in Latin America, providing instruments, reagents, and laboratory software to clinical-analysis labs across more than 50 countries from its Argentine base.
Ownership category
akta.pro rank

Wiener lab Group industry classification

Industry
Product category
In Vitro Diagnostics
NAICS
Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAO
Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGAIAN
Maintenance, Service Contracts & Equipment Repair (Field Service, Parts)

Keywords

  • In vitro diagnostics
  • Clinical chemistry reagents
  • Laboratory automation equipment
  • Diagnostic instruments
  • Laboratory information software

Where Wiener lab Group is headquartered

Location

Headquarters

HQ city
Rosario
HQ country
Argentina
HQ region
Latin America

Offices1 record

Markets served

Wiener lab Group business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Instrument Sales: Sale of clinical analysis instruments and automation equipment to laboratories. Equipment sales represent a significant revenue stream with typically higher transaction values and longer sales cycles associated with enterprise laboratory clients.
  2. Reagent Sales: Sale of diagnostic reagents and consumables required for clinical testing. Reagent sales provide recurring revenue as laboratories require ongoing supply for continuous diagnostic operations.
  3. Software Solutions: Sale and licensing of tailor-made IT software solutions for laboratory information management and diagnostic workflow optimization.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Wiener lab Group product offering

Product offering

Core offering

Wiener lab Group is the largest in vitro diagnostic company in Latin America, selling a comprehensive portfolio of more than 500 diagnostic solutions to clinical analysis laboratories. Its offering comprises three core product lines: clinical analysis Instruments (laboratory automation equipment), Reagents (innovative and affordable diagnostic reagent systems), and tailor-made Software (IT solutions for laboratory information management and workflow optimization). The company also provides permanent technical customer support delivered by an interdisciplinary team of biochemists, engineers and technicians.

Product overview

Wiener lab Group is the largest in vitro diagnostic company in Latin America, offering a unified platform of diagnostic solutions comprising three core product lines: Instruments (laboratory automation equipment), Reagents (diagnostic systems), and Software (IT solutions). Together, these products provide comprehensive solutions for clinical analysis laboratories of various sizes, spanning over 500 diagnostic solutions across more than 50 countries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Instruments Wide range of laboratory equipment designed to automate clinical analysis laboratories of various sizes, providing comprehensive solutions for laboratory automation and clinical analysis workflows. Targeted at clinical analysis laboratories ranging from small standalone labs to large hospital laboratories.
  • Reagents Innovative, reliable, and affordable diagnostic reagent systems used for in vitro diagnostics, forming a core component of the company's diagnostic solution portfolio and providing recurring consumables for clinical laboratories.
  • Software Tailor-made IT solutions designed to complement the diagnostic instruments and reagents, providing integrated information technology support for laboratory information management and diagnostic workflow optimization.

Companies that use Wiener lab Group

Customer profile

Segments1 record

Ideal customer profiles1 record

Wiener lab Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Wiener lab Group partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves3 records

Expansion highlights2 records

Wiener lab Group competitors and assessment

Company assessment

Direct peers

  • Bio-Rad Laboratories: Diversified life science and clinical diagnostics company with a clinical IVD portfolio in immunology, blood typing, and QC materials. Comparable in selling reagents and instruments to clinical analysis labs and in emerging-market distribution.
  • DiaSorin: Specialty IVD company with a focused reagent and instrument menu (LIAISON) in clinical chemistry and immunoassays. Comparable in scale, vertically integrated model, and reliance on recurring reagent revenue from clinical labs.
  • bioMérieux: Specialty IVD company focused on microbiology, immunoassays, and clinical chemistry with strong emerging-market presence. Closely comparable business model (instruments + reagents, recurring consumables) and similar target of mid-sized clinical labs in developing markets.
  • Erba Mannheim: Mid-sized IVD company offering clinical chemistry, hematology, and immunoassay instruments and reagents with strong emerging-market focus. Closely comparable in scale, product mix, and pricing-oriented positioning against global giants.

Broad incumbents

  • Beckman Coulter (Danaher): Global IVD player in clinical chemistry, immunoassay, and hematology with strong mid-tier lab presence. Comparable in customer segment, instrument-reagent model, and competition for hospital and reference lab contracts in the region.
  • Siemens Healthineers: Major IVD and diagnostics informatics provider (Atellica, ADVIA Centaur). Comparable as a full-stack instruments + reagents + LIS competitor in mid- and large-sized hospital laboratories across Latin America.
  • Sysmex: Global IVD leader in hematology and urinalysis with expanding clinical chemistry offerings. Comparable in instruments + reagents model and in competing for routine testing workloads in hospital and reference labs.
  • Roche Diagnostics: Global IVD leader with the broadest integrated instruments/reagents/software portfolio (cobas, Elecsys, etc.). Comparable as the benchmark integrated IVD player that Wiener lab competes against, especially in Latin American hospital labs.
  • Abbott Diagnostics: Global IVD incumbent with ARCHITECT and Alinity platforms spanning clinical chemistry and immunoassays. Directly comparable in product mix and target customer (clinical analysis labs) and a key competitor across LatAm.

Emerging players

  • Mindray: Fast-growing Chinese IVD and medical device manufacturer with an aggressive push into Latin America and emerging markets. Directly comparable in targeting mid-tier labs with cost-competitive instruments and reagents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Wiener lab Group social profiles

Digital presence

Wiener lab Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wiener lab Group leadership team

Management profile

Number of profiles

Wiener lab Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wiener lab Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wiener lab Group

What does Wiener lab Group do?

Wiener lab Group is the largest in vitro diagnostic company in Latin America, selling a comprehensive portfolio of more than 500 diagnostic solutions to clinical analysis laboratories. Its offering comprises three core product lines: clinical analysis Instruments (laboratory automation equipment), Reagents (innovative and affordable diagnostic reagent systems), and tailor-made Software (IT solutions for laboratory information management and workflow optimization). The company also provides permanent technical customer support delivered by an interdisciplinary team of biochemists, engineers and technicians.

Is Wiener lab Group a public or private company?

Wiener lab Group is a private company. It is classified as unknown and is currently operating.

When was Wiener lab Group founded?

Wiener lab Group was founded in 1960. It employs 1 to 10 people.

Where is Wiener lab Group based?

Wiener lab Group is headquartered in Rosario, Argentina, in the Latin America region.

How does Wiener lab Group make money?

Three revenue lines are on record. Instrument Sales are the primary driver. The others are reagent Sales and software Solutions.

Who are Wiener lab Group's main competitors?

Direct peers on record are Bio-Rad Laboratories, DiaSorin, bioMérieux and Erba Mannheim. Broad incumbents are Beckman Coulter (Danaher), Siemens Healthineers, Sysmex, Roche Diagnostics and Abbott Diagnostics. Mindray is listed as an emerging player.

Does Wiener lab Group have an API?

No public API is recorded for Wiener lab Group.

What industry is Wiener lab Group in?

Wiener lab Group's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAHAAAO, Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals